Ability Bio is a biotechnology company focused on developing advanced therapies for rare and devastating diseases. Their approach combines cutting-edge science with a commitment to improving patient outcomes.

Our Mission:Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.The premier biotherapeutic targeting companyOur powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need. 

BIO:ABILITY

Ability Bio

Analysis Not Available